Troluce Capital Advisors »

Cytokinetics shares owned by Troluce Capital Advisors

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Troluce Capital Advisors from 13F filings

Historical chart of Troluce Capital Advisors investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Troluce Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Troluce Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $12M 175k 70.11

More positions owned by Troluce Capital Advisors

American Intl Group Com New (AIG)
Invesco Exchange Traded Fd T S&p500 Eql Wgt Put Option (RSP)
Liberty Media Corp Del Com Lbty Liv S C (LLYVK)
Capital One Financial (COF)
Broadcom Call Option (AVGO)
CRH Ord Put Option (CRH)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
General Electric
Tko Group Holdings Cl A Put Option (TKO)
Ansys (ANSS)
Corebridge Finl Put Option (CRBG)
Lazard Ltd Shs -a - (LAZ)
Western Digital Call Option (WDC)
Sirius Xm Holdings Put Option (SIRI)
3M Company Call Option (MMM)

View all positions for Troluce Capital Advisors

Top funds holding Cytokinetics

BlackRock
FMR
Vanguard Group
Wellington Management Company
Bank of America Corporation
T. Rowe Price Investment Management
T. Rowe Price Associates
Marshall Wace
Pentwater Capital Management
Geode Capital Management
Armistice Capital
HAP Trading
Susquehanna International
Boxer Capital
Melqart Asset Management

View all funds holding Cytokinetics